Ultragenyx Pharmaceutical Inc. (RARE)

$48.38 -4.64% $-2.36 Healthcare

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc., Solid Biosciences Inc.; and Daiichi Sankyo Co., Ltd. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California.

$4.47B

Dr. Emil D. Kakkis M.D., Ph.D.

1,119.00

Novato, CA

Jan 31, 2014

-7.62

$-6.35

0.29

2.36

-154.87%

-4.38

87.77

7.70

2.05

-51.31%

-346.34%

Similar stocks (12)

Alnylam Pharmaceuticals, Inc.

ALNY

$268.95 -3.88%
Uptrend

Incyte Corporation

INCY

$80.58 -1.17%
Uptrend

Revolution Medicines, Inc.

RVMD

$59.46 -1.88%
Uptrend

Crinetics Pharmaceuticals, Inc.

CRNX

$58.78 -2.05%
Uptrend

Apellis Pharmaceuticals, Inc.

APLS

$29.26 -1.08%
Downtrend

Arvinas, Inc.

ARVN

$26.31 -6.17%
Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$15.64 -1.39%
Neutral

Kura Oncology, Inc.

KURA

$18.57 5.75%
Downtrend

Amylyx Pharmaceuticals, Inc.

AMLX

$6.24 -11.24%
Neutral

Inozyme Pharma, Inc.

INZY

$3.76 -6.00%
Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.68 -16.93%
Neutral

PDS Biotechnology Corporation

PDSB

$2.96 -8.95%
Downtrend

ETF Exposure (44)

Global X Genomics & Biotechnology ETF

GNOM

3.52%

$10.57 -2.94%
Downtrend

First Trust Health Care AlphaDEX Fund

FXH

1.92%

$111.15 -1.39%
Uptrend

Franklin Genomic Advancements ETF

HELX

1.46%

$31.23 -0.61%
Downtrend

First Trust Multi-Manager Large Growth ETF

MMLG

0.84%

$30.40 0.90%
Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.455411073%

$131.90 -8.64%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.454%

$23.77 -2.42%
Uptrend

iShares Biotechnology ETF

IBB

0.40083%

$144.36 -2.27%
Uptrend

First Trust Multi-Manager Small Cap Opportunities ETF

MMSC

0.39%

$22.19 -1.79%
Uptrend

BlackRock Future Health ETF

BMED

0.38426%

$26.22 -0.83%
Uptrend

First Trust Mid Cap Growth AlphaDEX Fund

FNY

0.35%

$85.84 -1.34%
Uptrend

Etho Climate Leadership U.S. ETF

ETHO

0.33%

$62.75 -1.13%
Uptrend

ProShares MSCI Transformational Changes ETF

ANEW

0.22704347731513022%

$45.83 -1.07%
Uptrend

iShares Morningstar Small-Cap Growth ETF

ISCG

0.15808%

$52.74 -1.35%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.1412374515%

$27.60 -1.55%
Uptrend

iShares Russell Mid-Cap Growth ETF

IWP

0.13718%

$131.20 -0.54%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.13232326058179755%

$62.76 -5.40%
Uptrend

First Trust Mid Cap Core AlphaDEX Fund

FNX

0.12%

$123.24 -1.34%
Uptrend

First Trust Multi Cap Growth AlphaDEX Fund

FAD

0.11%

$145.89 -0.86%
Uptrend

SPDR S&P Kensho New Economies Composite ETF

KOMP

0.102421%

$53.60 -1.52%
Uptrend

JPMorgan BetaBuilders U.S. Mid Cap Equity ETF

BBMC

0.1%

$101.51 -0.94%
Uptrend

iShares Morningstar Small-Cap ETF

ISCB

0.08016%

$62.50 -1.39%
Uptrend

iShares U.S. Healthcare ETF

IYH

0.07703%

$62.18 -1.41%
Neutral

Fidelity MSCI Health Care Index ETF

FHLC

0.07035395%

$70.21 -1.45%
Neutral

Invesco Russell 1000 Equal Weight ETF

EQAL

0.068%

$50.57 -0.73%
Uptrend

iShares ESG Aware MSCI USA Small-Cap ETF

ESML

0.06525%

$44.63 -1.35%
Uptrend

John Hancock Multifactor Mid Cap ETF

JHMM

0.06%

$63.10 -0.90%
Uptrend

Vanguard Small Cap Index Fund

NAESX

0.06%

$122.72 1.19%
Uptrend

iShares Russell Mid-Cap ETF

IWR

0.03493%

$92.81 -0.77%
Uptrend

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.021%

$44.25 -1.54%
Uptrend

John Hancock Multifactor Small Cap ETF

JHSC

0.02%

$42.61 -1.76%
Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0.02%

$75.82 -0.41%
Uptrend

iShares Russell 1000 Growth ETF

IWF

0.01473%

$398.79 0.08%
Uptrend

Vanguard ESG U.S. Stock ETF

ESGV

0.01%

$106.49 -0.25%
Uptrend

Columbia Research Enhanced Core ETF

RECS

0.01%

$35.62 -0.15%
Uptrend

Columbia Research Enhanced Value ETF

REVS

0.01%

$26.36 -0.64%
Uptrend

Schwab 1000 Index ETF

SCHK

0.009858032%

$28.84 -0.55%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0093527879%

$23.18 -0.56%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00785%

$131.55 -0.45%
Uptrend

iShares Dow Jones U.S. ETF

IYY

0.00781%

$146.02 -0.24%
Uptrend

iShares Russell 3000 ETF

IWV

0.00771%

$342.01 -0.45%
Uptrend

iShares Russell 1000 ETF

IWB

0.00755%

$328.79 -0.32%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

0.00109086%

$35.93 -0.53%
Uptrend

Goldman Sachs Future Health Care Equity ETF

GDOC

0%

$34.14 -1.01%
Downtrend

Goldman Sachs JUST U.S. Large Cap Equity ETF

JUST

0%

$84.90 -0.12%
Uptrend